--- title: "Lifevantage (LFVN) stock listing, news and investor profile" url: "https://aibio.space/companies/lifevantage/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Lifevantage Corp (NASDAQ: LFVN), United States. Listing facts, related biotech companies and news on aibio.space." --- LFVN Lifevantage Corp NASDAQ · United States # Lifevantage (LFVN) news Lifevantage Corp is a public biotech or pharmaceutical company listed on NASDAQ under the ticker LFVN, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Lifevantage news We have not published a story on Lifevantage yet. When there is news, it will appear here. ## Lifevantage at a glance - **Ticker**: LFVN - **Listing**: NASDAQ - **Country**: United States - **Cash, Jun 30, 2026**: $14.9 million ### Related companies - [Revium Rx.](https://aibio.space/companies/revium-rx/) OTC: RVRC - [Pulsenmore](https://aibio.space/companies/pulsenmore/) NASDAQ: PLSM - [Neuraxis, INC](https://aibio.space/companies/neuraxis/) NYSE: NRXS - [WATERS CORP /DE/](https://aibio.space/companies/waters-de/) NYSE: WAT - [Glucose Health](https://aibio.space/companies/glucose-health/) OTC: GLUC - [Bespoke Extracts](https://aibio.space/companies/bespoke-extracts/) OTC: BSPK - [GRAIL](https://aibio.space/companies/grail/) NASDAQ: GRAL - [PANACEA LIFE SCIENCES HOLDINGS, INC.](https://aibio.space/companies/panacea-life-sciences/) OTC: PLSH ### Also on NASDAQ - [Iambic Therapeutics](https://aibio.space/companies/iambic-therapeutics/) IAM - [Nexalin Technology](https://aibio.space/companies/nexalin-technology/) NXL - [Ceribell](https://aibio.space/companies/ceribell/) CBLL - [SeaStar Medical Holding](https://aibio.space/companies/seastar-medical/) ICU - [Generate Biomedicines](https://aibio.space/companies/generate-biomedicines/) GENB - [Taysha Gene Therapies](https://aibio.space/companies/taysha-gene-therapies/) TSHA ## What Lifevantage does LifeVantage Corporation is a company focused on nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. It identifies, researches, develops, formulates and sells nutrigenomic activators, dietary supplements, weight management products, gut health products, skin and hair care products, and nootropics. Its flagship line is Protandim, and other lines include the MindBody GLP-1 System, the P84 System for gut health, TrueScience skin and hair care products, Liquid Collagen, Petandim for dogs, and AXIO nootropic and energy and hydration drink mixes. Products are sold through a commission-based direct sales model that uses independent consultants, in markets including the United States, Mexico, Canada, Japan, Taiwan, Thailand, Australia, New Zealand, the United Kingdom and several European countries. In October 2025 the company acquired the critical operating assets of LoveBiome, and it launched four of the acquired products in the United States during fiscal year 2026. It is also modernizing its digital commerce platform. | Product or program | What it is | Stage | |---|---|---| | Protandim | Flagship line of scientifically validated dietary supplements | sold | | P84 System | Two-product activator system that helps regulate, repair and restore gut health | launched in the United States | | MindBody GLP-1 System | Dietary supplement system, sold internationally as the MB System | launched in Canada and Europe | | TrueScience | Skin and hair care products | sold | | Petandim | Chewable companion supplement for dogs | introduced in Mexico | | AXIO | Nootropic and energy and hydration drink mixes | AXIO X and AXIO Hydrate launched in the United States | Summarised from the company's [10-K filed Aug 27, 2026](https://www.sec.gov/Archives/edgar/data/849146/000119312526371257/lfvn-20260630.htm). ## Lifevantage annual financials | Line | FY ended Jun 30, 2026 | FY ended Jun 30, 2025 | |---|---|---| | Research and development | [$1.0 million](https://www.sec.gov/Archives/edgar/data/849146/000119312526371257/) | [$1.4 million](https://www.sec.gov/Archives/edgar/data/849146/000119312526371257/) | | Net income (loss) | [$5.1 million](https://www.sec.gov/Archives/edgar/data/849146/000119312526371257/) | [$9.8 million](https://www.sec.gov/Archives/edgar/data/849146/000119312526371257/) | | Cash from operations | [$10.2 million](https://www.sec.gov/Archives/edgar/data/849146/000119312526371257/) | [$11.9 million](https://www.sec.gov/Archives/edgar/data/849146/000119312526371257/) | | Cash and equivalents | [$14.9 million](https://www.sec.gov/Archives/edgar/data/849146/000119312526371257/) | [$20.2 million](https://www.sec.gov/Archives/edgar/data/849146/000084914625000068/) | Latest balance sheet, Jun 30, 2026 (10-K): cash and equivalents $14.9 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Lifevantage What is the ticker symbol of Lifevantage? Lifevantage Corp trades under the ticker LFVN on NASDAQ. Where is Lifevantage listed? Lifevantage Corp is listed on NASDAQ. Which country or territory is Lifevantage listed under? Our directory records Lifevantage Corp under United States. Does aibio.space cover Lifevantage? aibio.space lists Lifevantage Corp among 2,820 public biotech companies and publishes its news here as stories appear. What does Lifevantage develop? LifeVantage Corporation is a company focused on nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. It identifies, researches, develops, formulates and sells nutrigenomic activators, dietary supplements, weight management products, gut health products, skin and hair care products, and nootropics. What is Protandim from Lifevantage? Protandim: Flagship line of scientifically validated dietary supplements Stage: sold. What is P84 System from Lifevantage? P84 System: Two-product activator system that helps regulate, repair and restore gut health Stage: launched in the United States. Is Lifevantage profitable? Lifevantage Corp reported net income of $5.1 million for the fiscal year ended Jun 30, 2026, and generated $10.2 million of cash from operations, per its annual report to the SEC. How much does Lifevantage spend on research and development? $1.0 million in the fiscal year ended Jun 30, 2026, per its annual report. How much cash does Lifevantage have? $14.9 million in cash at Jun 30, 2026, per its 10-K. ## Investor discussion: Lifevantage Members talk about Lifevantage (LFVN). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:LFVN on TradingView](https://www.tradingview.com/symbols/NASDAQ-LFVN/). ## Listing details Lifevantage Corp is a public biotech or pharmaceutical company listed on NASDAQ under the ticker LFVN, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Lifevantage Corp - **Ticker**: LFVN - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/lifevantage/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Lifevantage (LFVN) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/lifevantage/